Impact of HCV Genome Structure on Responder to Pegylated Interferon Therapy in Egyptian Patients | Mohamed Eldesouky

Impact of HCV Genome Structure on Responder to Pegylated Interferon Therapy in Egyptian Patients

Citation:: Abdallah, S. O., M. A. El-Dessouky, M. H. Hassanein, H. Omar, and K. M. F. E. Sehrawy, "Impact of HCV Genome Structure on Responder to Pegylated Interferon Therapy in Egyptian Patients", International Journal of Pharmaceutical Research & Allied Sciences, vol. 8, issue 3, pp. 61-68, 2019.